Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

416 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies.
Weiss C, Weiller E, Baker RA, Duffy RA, Gwin KK, Zhang P, McQuade RD. Weiss C, et al. Among authors: baker ra. Int Clin Psychopharmacol. 2018 Sep;33(5):255-260. doi: 10.1097/YIC.0000000000000226. Int Clin Psychopharmacol. 2018. PMID: 29878915 Free PMC article.
Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians' choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study.
Correll CU, Shi L, Weiss C, Hobart M, Eramo A, Duffy RA, Weiller E, Baker RA. Correll CU, et al. Among authors: baker ra. CNS Spectr. 2019 Oct;24(5):507-517. doi: 10.1017/S1092852918001086. CNS Spectr. 2019. PMID: 30306884 Clinical Trial.
Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review.
Aigbogun MS, Cloutier M, Gauthier-Loiselle M, Guerin A, Ladouceur M, Baker RA, Grundman M, Duffy RA, Hartry A, Gwin K, Fillit H. Aigbogun MS, et al. Among authors: baker ra. J Alzheimers Dis. 2020;77(3):1181-1194. doi: 10.3233/JAD-200127. J Alzheimers Dis. 2020. PMID: 32925028 Free PMC article. Clinical Trial.
Institutionalization risk and costs associated with agitation in Alzheimer's disease.
Cloutier M, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Guerin A, Hartry A, Baker RA, Duffy R, Gwin K, Sanon Aigbogun M. Cloutier M, et al. Among authors: baker ra. Alzheimers Dement (N Y). 2019 Nov 23;5:851-861. doi: 10.1016/j.trci.2019.10.004. eCollection 2019. Alzheimers Dement (N Y). 2019. PMID: 31799369 Free PMC article.
Impact of agitation in long-term care residents with dementia in the United States.
Fillit H, Aigbogun MS, Gagnon-Sanschagrin P, Cloutier M, Davidson M, Serra E, Guérin A, Baker RA, Houle CR, Grossberg G. Fillit H, et al. Among authors: baker ra. Int J Geriatr Psychiatry. 2021 Dec;36(12):1959-1969. doi: 10.1002/gps.5604. Epub 2021 Aug 27. Int J Geriatr Psychiatry. 2021. PMID: 34286877 Free PMC article.
416 results